Article Content

Cardiovascular Nursing Symposium

The Preventive Cardiovascular Nurses Association's (PCNA's) 27th Annual Cardiovascular Nursing Symposium will continue our tradition of combining clinically relevant content with an intimate setting that allows you to return to your practice rejuvenated and energized. Although the Cardiovascular Nursing Symposium is being held virtually this year, it will maintain the high-quality education and world-renowned speakers you expect from our live meeting.

 

The Cardiovascular Nursing Symposium General Sessions will be held on April 8-9, 2021.

 

Earn 7.5 CE contact hours, including 1.0 pharmacology at this 2-day program, which will include a virtual exhibit hall and poster sessions, and cover the hottest topics in the field. Sessions include the following:

 

* Cardiovascular Disease (CVD) Prevention and Management: Top 5 Cardiovascular Clinical Trials of 2020-2021

 

* COVID-19 and CVD: What Have We Learned?

 

* Telehealth and Virtual Patient Care: Best Practices

 

* Challenge of CVD Risk Reduction in Racial and Ethnic Minorities

 

* Managing Stable Coronary Artery Disease: Invasive vs Conservative Approach

 

* Can Stenting Prevent Myocardial Infarction in Stable Coronary Heart Disease?

 

* Cases: Lifestyle, Medication, and Intervention to Manage Stable Coronary Heart Disease

 

* Best Practices in Stroke Prevention: Risk Factor Management or Surgery?

 

* Substance Abuse and Cardiovascular Disease

 

* Fearless Soul: The Call to Nursing and the Courage to Stay

 

 

The PCNA's Cardiovascular Nursing Symposium continues with a skill-building workshop on May 6-7. Earn 5.0 CE contact hours and develop your clinical skills with sessions on the following topics:

 

* Interpreting and Applying the 12-Lead ECG in Clinical Settings

 

* Heart Sounds: What Is Your Patient's Heart Telling You?

 

* Behavior Change Principles in Action: Helping Patients Set Goals and Follow a Heart-Healthy Eating Plan

 

* Improving Medication Adherence

 

 

Learn more and register at https://pcna.net/cardiovascular-nursing-symposium/.

 

New Patient Tool: Statin Side Effects

Statins are the criterion standard for managing dyslipidemia in patients with an elevated cardiovascular risk. The benefits of statins in primary and secondary prevention are among the most studied in modern medicine. Although their safety has been well documented, statin intolerance continues to be a major concern, resulting in nonadherence or discontinuation of therapy. An estimated 50% of patients with coronary heart disease discontinue statin therapy after 1 year, placing them at an increased risk of acute cardiovascular events including heart attack and stroke.1

 

Statin intolerance occurs when a person can no longer take a statin, either because of a symptom or side effect or for safety concerns related to elevated liver or muscle enzymes in the blood. The most common presentation of statin intolerance is generalized muscle aches, pains, weakness, or cramps commonly referred to as myalgia.

 

An important component of improving medication adherence is patient-centered communication and shared decision making. Tools and resources that provide current and accurate information regarding statin intolerance are needed to frame patient/clinician conversations and decisions around statin intolerance.

 

The PCNA's new tool, "Statin Medicine Side Effects-What You Need to Know," will help your patients with medication adherence and improved outcomes-even when they cannot continue taking their statin because of a symptom or side effect. This tool is designed to reduce patients' unease and increase their understanding as you work together to reduce their low-density lipoprotein.

 

This 2-sided sheet describes the following:

 

* Statins

 

* Side effects

 

* Who is at risk for side effects

 

* How providers and patients will work together to address side effects

 

 

This 2-sided tool is available in English and can be downloaded or ordered in sets of 25 sheets. Members of the PCNA can order hard copies at no charge. Get this tool and other cholesterol patient education tools and handouts at https://pcna.net/clinical-resources/patient-handouts/cholesterol-patient-tools-a.

 

REFERENCE

 

1. Toth PP, Patti AM, Giglio RV, et al. Management of statin intolerance in 2018: still more questions than answers. Am J Cardiovasc Drugs. 2018;18(3):157-173. [Context Link]